Ulrich V. Eitzen

625 total citations
10 papers, 509 citations indexed

About

Ulrich V. Eitzen is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, Ulrich V. Eitzen has authored 10 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Neurology and 3 papers in Neurology. Recurrent topics in Ulrich V. Eitzen's work include Neurological diseases and metabolism (3 papers), Mitochondrial Function and Pathology (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Ulrich V. Eitzen is often cited by papers focused on Neurological diseases and metabolism (3 papers), Mitochondrial Function and Pathology (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Ulrich V. Eitzen collaborates with scholars based in Germany, Japan and United States. Ulrich V. Eitzen's co-authors include Manuel B. Graeber, Siegfried Kösel, Rupert Egensperger, Parviz Mehraein, E. M. Grasbon-Frodl, Doris Meier-Tackmann, H. W. Goedde, Dharam P. Agarwal, Yoshinori Imai and Shinichi Kohsaka and has published in prestigious journals such as Acta Neuropathologica, Cancer Letters and Journal of Neuropathology & Experimental Neurology.

In The Last Decade

Ulrich V. Eitzen

10 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrich V. Eitzen Germany 8 262 174 161 149 139 10 509
Salomé McAllen United States 13 285 1.1× 197 1.1× 389 2.4× 124 0.8× 126 0.9× 17 665
Carlos Lorenzana United States 4 184 0.7× 132 0.8× 69 0.4× 112 0.8× 50 0.4× 4 438
Eli C. Levin United States 6 146 0.6× 140 0.8× 154 1.0× 65 0.4× 50 0.4× 7 397
Ayami Nakazawa Japan 13 262 1.0× 63 0.4× 96 0.6× 41 0.3× 128 0.9× 19 479
Keigo Goto Japan 10 210 0.8× 64 0.4× 99 0.6× 229 1.5× 226 1.6× 15 541
Kenji Ikeda Japan 8 173 0.7× 104 0.6× 242 1.5× 47 0.3× 77 0.6× 14 419
Alvin Joselin Canada 8 343 1.3× 66 0.4× 151 0.9× 260 1.7× 121 0.9× 12 636
Karen Duong‐Polk United States 12 384 1.5× 76 0.4× 78 0.5× 45 0.3× 74 0.5× 16 603
Yogita Dheer Australia 15 360 1.4× 99 0.6× 150 0.9× 49 0.3× 73 0.5× 18 683
Emmanuelle C. Genin France 11 286 1.1× 54 0.3× 90 0.6× 134 0.9× 45 0.3× 15 408

Countries citing papers authored by Ulrich V. Eitzen

Since Specialization
Citations

This map shows the geographic impact of Ulrich V. Eitzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich V. Eitzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich V. Eitzen more than expected).

Fields of papers citing papers by Ulrich V. Eitzen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrich V. Eitzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich V. Eitzen. The network helps show where Ulrich V. Eitzen may publish in the future.

Co-authorship network of co-authors of Ulrich V. Eitzen

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrich V. Eitzen. A scholar is included among the top collaborators of Ulrich V. Eitzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrich V. Eitzen. Ulrich V. Eitzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Grasbon-Frodl, E. M., Siegfried Kösel, Mathias Sprinzl, et al.. (1999). Two novel point mutations of mitochondrial tRNA genes in histologically confirmed Parkinson disease. Neurogenetics. 2(2). 121–127. 39 indexed citations
2.
Graeber, Manuel B., et al.. (1998). Neurodegeneration and aging: Role of the second genome. Journal of Neuroscience Research. 52(1). 1–6. 30 indexed citations
3.
Egensperger, Rupert, Siegfried Kösel, Ulrich V. Eitzen, & Manuel B. Graeber. (1998). Microglial Activation in Alzheimer Disease: Association with APOE Genotype. Brain Pathology. 8(3). 439–447. 126 indexed citations
4.
Eitzen, Ulrich V., Rupert Egensperger, Siegfried Kösel, et al.. (1998). Microglia and the Development of Spongiform Change in Creutzfeldt-Jakob Disease. Journal of Neuropathology & Experimental Neurology. 57(3). 246–256. 80 indexed citations
5.
Kösel, Siegfried, E. M. Grasbon-Frodl, Rupert Egensperger, et al.. (1998). Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease. Neurogenetics. 1(3). 197–204. 71 indexed citations
6.
Graeber, Manuel B., E. M. Grasbon-Frodl, Ulrich V. Eitzen, & Siegfried Kösel. (1998). Neurodegeneration and aging: Role of the second genome. Journal of Neuroscience Research. 52(1). 1–6. 3 indexed citations
7.
Kösel, Siegfried, Rupert Egensperger, Ulrich V. Eitzen, Parviz Mehraein, & Manuel B. Graeber. (1997). On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropathologica. 93(2). 105–108. 113 indexed citations
8.
Agarwal, Dharam P., Ulrich V. Eitzen, Doris Meier-Tackmann, & H. W. Goedde. (1995). Metabolism of Cyclophosphamide by Aldehyde Dehydrogenases. Advances in experimental medicine and biology. 372. 115–122. 13 indexed citations
9.
Eitzen, Ulrich V., Doris Meier-Tackmann, Dharam P. Agarwal, & H. W. Goedde. (1994). Detoxification of cyclophosphamide by human aldehyde dehydrogenase isozymes. Cancer Letters. 76(1). 45–49. 32 indexed citations
10.
Meier-Tackmann, Doris, et al.. (1993). Tumor-Associated Aldehyde Dehydrogenase (ALDH3): Expression in Diffrent Human Tumor Cell Lines with and without Treatment with 3-Methylcholanthrene. Advances in experimental medicine and biology. 328. 115–122. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026